Non-Opioid Pain – Talk Bio

FDA Approves Vertex’s Journavx: A Breakthrough Non-Opioid Pain Medication

3 months ago talkbio0Tagged acute pain treatment, Approved, Inhibitor, Journavx, Non-Opioid Pain, Suzetrigine, United States Food and Drug Administration

Journavx, suzetrigine, Vertex Pharmaceuticals, FDA approval, non-opioid pain reliever, acute pain treatment, NaV1.8 inhibitor

SiteOne Therapeutics Secures $100M Series C Funding to Advance Non-Opioid Pain Treatments

4 months ago talkbio0Tagged Non-Opioid Pain, Peripheral Nervous System, sensory hyperexcitability disorders, Series, SiteOne Therapeutics

Non-opioid pain treatments, SiteOne Therapeutics, Series C funding, ion channel modulators, peripheral nervous system (PNS), sensory hyperexcitability disorders.

Novo Holdings Spearheads $100M Series C Financing for SiteOne Therapeutics to Develop Non-Opioid Pain Therapies

4 months ago talkbio0Tagged Holdings, ion channel modulators, Non-Opioid Pain, Opioid Epidemic, pain chronic management, Peripheral Nervous System, Series C financing, SiteOne Therapeutics

Novo Holdings, SiteOne Therapeutics, Non-opioid pain treatments, Series C financing, Ion channel modulators, Peripheral nervous system (PNS) pain treatments, Chronic pain management, Opioid epidemic